Mathis Charles Alexander
Known title: DirectorCIK: 0001438831
Mathis Charles Alexander's purchase track record
Mathis Charles Alexander has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/11/2026 | SCSC | $211K | +21.2% | +49.9% | +11.6% |
| 11/12/2021 | SCSC | $43K | -12.6% | +4.5% | -14.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SCSC | ▼ Sell | Open Market | 3,000 | $174K | 9/11/2026 | View on chart |
| SCSC | ▲ Buy | Grant | 3,234 | $0 | 9/1/2026 | View on chart |
| SCSC | ▲ Buy | Open Market | 1,000 | $35K | 2/11/2026 | View on chart |
| SCSC | ▲ Buy | Open Market | 5,000 | $177K | 2/11/2026 | View on chart |
| SCSC | ▲ Buy | Grant | 3,693 | $0 | 9/1/2025 | View on chart |
| SCSC | ▲ Buy | Grant | 3,141 | $0 | 8/30/2024 | View on chart |
| SCSC | ▼ Sell | Open Market | 1,000 | $47K | 5/13/2024 | View on chart |
| SCSC | ▼ Sell | Open Market | 2,000 | $94K | 5/10/2024 | View on chart |
| SCSC | ▲ Buy | Grant | 4,759 | $150K | 8/25/2023 | View on chart |
| SCSC | ▲ Buy | Grant | 5,300 | $152K | 8/26/2022 | View on chart |
| SCSC | ▲ Buy | Open Market | 1,200 | $43K | 11/12/2021 | View on chart |
| SCSC | ▲ Buy | Grant | 3,700 | $133K | 8/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Barclays Raises ScanSource Price Target to $51
Barclays maintained an Equal-Weight rating on ScanSource while raising its price target to $51. The firm highlighted the company's position within the technology services sector, which continues to face industry-wide challenges. This update provides a specific valuation benchmark for investors, sitting below the current average analyst target of $64.50.
Barclays Raises ScanSource Price Target to $51. Barclays maintained an Equal-Weight rating on ScanSource while raising its price target to $51. The firm highlighted the company's position within the technology services sector, which continues to face industry-wide challenges. This update provides a specific valuation benchmark for investors, sitting below the current average analyst target of $64.50.